Vaccines

How can our knowledge of mRNA vaccine development influence our Industry 4.0 journeys?

How one CDMO navigated the pandemic and came out on top of industry trends

Why, oh why, is there so much nonsense and misinformation about COVID-19 vaccines?

Optimizing mRNA in vitro transcription processes is important – and high-quality kits are a great starting point.

The Medicine Maker and NIBRT present the Biopharma Trends Leaders’ Report 2022.

It’s been a busy time for infectious disease vaccine news in Europe.

Our animated chart illustrates Pfizer’s changing fortunes – and the significant contribution its COVID-19 efforts have made to revenues.

With mRNA offering more straightforward development and manufacturing processes, are the days of traditional vaccine modalities numbered?

African vaccine production needs a boost. Here’s how Aspen is working to make that happen.

Driven by the success of COVID-19 vaccines, mRNA products are expanding drug developers’ pipelines.